ONCOLOGUES Trademark

Trademark Overview


On Monday, May 4, 2020, a trademark application was filed for ONCOLOGUES with the United States Patent and Trademark Office. The USPTO has given the ONCOLOGUES trademark a serial number of 88900007. The federal status of this trademark filing is REGISTERED as of Tuesday, March 29, 2022. This trademark is owned by Oncogenuity, Inc.. The ONCOLOGUES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of computer platform technology, namely, development of cancer immunotherapy software platforms for manufacturing therapeutics; Consulting services for others in the field of design, planning, and implementation of clinical trials; Information technology platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatment, in the medical field; Electronic data storage; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for ...
oncologues

General Information


Serial Number88900007
Word MarkONCOLOGUES
Filing DateMonday, May 4, 2020
Status700 - REGISTERED
Status DateTuesday, March 29, 2022
Registration Number6688308
Registration DateTuesday, March 29, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Translation of Words in MarkThe English translation of the word "ONCOLOGUES" in the mark is "ONCOLOGISTS".
Goods and ServicesPharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of computer platform technology, namely, development of cancer immunotherapy software platforms for manufacturing therapeutics; Consulting services for others in the field of design, planning, and implementation of clinical trials; Information technology platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatment, in the medical field; Electronic data storage; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code042
First Use Anywhere DateThursday, April 30, 2020
First Use In Commerce DateThursday, April 30, 2020

Trademark Owner History


Party NameOncogenuity, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Party NameOncogenuity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events


Event DateEvent Description
Tuesday, March 29, 2022REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, February 22, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 18, 2022ASSIGNED TO LIE
Monday, February 14, 2022APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, February 14, 2022EXAMINER'S AMENDMENT ENTERED
Monday, February 14, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 14, 2022EXAMINERS AMENDMENT E-MAILED
Monday, February 14, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, February 12, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, February 11, 2022USE AMENDMENT ACCEPTED
Thursday, January 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 27, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, January 27, 2022AMENDMENT TO USE PROCESSING COMPLETE
Thursday, January 27, 2022USE AMENDMENT FILED
Wednesday, January 26, 2022TEAS AMENDMENT OF USE RECEIVED
Wednesday, July 28, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 28, 2021FINAL REFUSAL E-MAILED
Wednesday, July 28, 2021FINAL REFUSAL WRITTEN
Monday, June 21, 2021ASSIGNED TO EXAMINER
Wednesday, February 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 4, 2020NON-FINAL ACTION E-MAILED
Tuesday, August 4, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 29, 2020ASSIGNED TO EXAMINER
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 7, 2020NEW APPLICATION ENTERED IN TRAM